Charles Muth - 07 May 2021 Form 4 Insider Report for BEYOND MEAT, INC. (BYND)

Signature
/s/ Teri L. Witteman, as Attorney-In-Fact for Charles Muth
Issuer symbol
BYND
Transactions as of
07 May 2021
Net transactions value
-$978,410
Form type
4
Filing time
11 May 2021, 20:10:48 UTC
Next filing
03 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BYND Common Stock Options Exercise $99,999 +33,333 +87% $3.00* 71,779 07 May 2021 Direct
transaction BYND Common Stock Sale $269,168 -2,500 -3.5% $107.67* 69,279 07 May 2021 Direct F1, F2
transaction BYND Common Stock Sale $398,809 -3,702 -37% $107.73* 6,298 07 May 2021 By Laura Christine Muth 2020 Irrevocable Trust F1, F3
transaction BYND Common Stock Sale $108,620 -1,000 -16% $108.62* 5,298 07 May 2021 By Laura Christine Muth 2020 Irrevocable Trust F1, F4
transaction BYND Common Stock Sale $32,662 -298 -5.6% $109.60* 5,000 07 May 2021 By Laura Christine Muth 2020 Irrevocable Trust F1, F5
transaction BYND Common Stock Sale $269,150 -2,500 -50% $107.66* 2,500 07 May 2021 By Charles James Muth 2020 Irrevocable Trust F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BYND Stock Option (right to buy) Options Exercise $0 -33,333 -53% $0.000000 29,586 07 May 2021 Common Stock 33,333 $3.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $107.06 to $107.945. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $107.06 to $108.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $108.08 to $108.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $109.41 to $109.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $107.11 to $107.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 Exercise of stock option granted under the 2011 Equity Incentive Plan on February 15, 2018; the option vested and became exercisable as to 25% of the total shares on May 30, 2018, and 1/48th of the total shares vests and becomes exercisable monthly thereafter such that the option is fully vested and exercisable on May 30, 2021, subject to an Executive Change in Control Severance Agreement by and between the Reporting Person and the Issuer.